ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 200 filers reported holding ANI PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $169,166,875 | -3.3% | 2,656,515 | +4.9% | 0.00% | 0.0% |
| Q1 2024 | $174,991,742 | +25.7% | 2,531,343 | +0.3% | 0.00% | 0.0% |
| Q4 2023 | $139,222,601 | -4.1% | 2,524,893 | +1.0% | 0.00% | 0.0% |
| Q3 2023 | $145,206,319 | +26.5% | 2,500,970 | +17.2% | 0.00% | +33.3% |
| Q2 2023 | $114,824,773 | +48.9% | 2,133,100 | +9.9% | 0.00% | +50.0% |
| Q1 2023 | $77,124,245 | -3.4% | 1,941,698 | -2.1% | 0.00% | -33.3% |
| Q4 2022 | $79,800,427 | +29.0% | 1,983,605 | +3.0% | 0.00% | +50.0% |
| Q3 2022 | $61,872,000 | +5.4% | 1,925,102 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $58,703,000 | +12.7% | 1,978,493 | +6.7% | 0.00% | +100.0% |
| Q1 2022 | $52,103,000 | -33.0% | 1,853,463 | +9.9% | 0.00% | -50.0% |
| Q4 2021 | $77,721,000 | +56.7% | 1,686,613 | +11.6% | 0.00% | +100.0% |
| Q3 2021 | $49,611,000 | -8.4% | 1,511,629 | -2.2% | 0.00% | -50.0% |
| Q2 2021 | $54,161,000 | -9.2% | 1,545,280 | -6.4% | 0.00% | 0.0% |
| Q1 2021 | $59,677,000 | +29.3% | 1,651,285 | +3.9% | 0.00% | +100.0% |
| Q4 2020 | $46,151,000 | +8.0% | 1,589,228 | +4.9% | 0.00% | -50.0% |
| Q3 2020 | $42,737,000 | -13.5% | 1,514,997 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $49,394,000 | -16.8% | 1,527,324 | +4.8% | 0.00% | -33.3% |
| Q1 2020 | $59,352,000 | -37.8% | 1,456,849 | -5.9% | 0.00% | -25.0% |
| Q4 2019 | $95,450,000 | -14.9% | 1,547,749 | +0.6% | 0.00% | -20.0% |
| Q3 2019 | $112,132,000 | -4.6% | 1,538,550 | +7.6% | 0.01% | 0.0% |
| Q2 2019 | $117,524,000 | +22.5% | 1,429,732 | +5.1% | 0.01% | +25.0% |
| Q1 2019 | $95,943,000 | +55.7% | 1,360,111 | -0.6% | 0.00% | +33.3% |
| Q4 2018 | $61,618,000 | -21.4% | 1,368,668 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $78,384,000 | -15.7% | 1,386,354 | -0.3% | 0.00% | -25.0% |
| Q2 2018 | $92,931,000 | +23.1% | 1,391,174 | +7.3% | 0.00% | 0.0% |
| Q1 2018 | $75,478,000 | -8.1% | 1,296,388 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $82,132,000 | +22.8% | 1,274,351 | +0.0% | 0.00% | +33.3% |
| Q3 2017 | $66,887,000 | +23.6% | 1,274,281 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $54,127,000 | -3.4% | 1,156,557 | +2.2% | 0.00% | 0.0% |
| Q1 2017 | $56,010,000 | +151278.4% | 1,131,313 | +183554.7% | 0.00% | – |
| Q4 2016 | $37,000 | -27.5% | 616 | -19.8% | 0.00% | – |
| Q3 2016 | $51,000 | +41.7% | 768 | +19.1% | 0.00% | – |
| Q2 2016 | $36,000 | +125.0% | 645 | +35.2% | 0.00% | – |
| Q1 2016 | $16,000 | +128.6% | 477 | +220.1% | 0.00% | – |
| Q4 2015 | $7,000 | +16.7% | 149 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -33.3% | 149 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | -18.2% | 149 | -15.3% | 0.00% | – |
| Q1 2015 | $11,000 | +10.0% | 176 | 0.0% | 0.00% | – |
| Q4 2014 | $10,000 | +100.0% | 176 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | -16.7% | 176 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 239,101 | $8,380,000 | 2.93% |
| Mesirow Financial Investment Management, Inc. | 8,974 | $315,000 | 0.80% |
| Parkman Healthcare Partners LLC | 55,346 | $1,940,000 | 0.42% |
| 1492 Capital Management LLC | 18,178 | $637,000 | 0.32% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 383,696 | $13,449,000 | 0.31% |
| PERKINS CAPITAL MANAGEMENT INC | 14,076 | $493,000 | 0.28% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 30,400 | $1,066,000 | 0.22% |
| Defender Capital, LLC. | 19,000 | $665,000 | 0.22% |
| Ranger Investment Management | 104,941 | $3,678,000 | 0.19% |
| THOMPSON SIEGEL & WALMSLEY LLC | 380,474 | $13,336,000 | 0.18% |